Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP
Torbjorn Tomson, Dina Battino, Erminio Bonizzoni, John Craig, Dick Lindhout, Emilio Perucca, Anne Sabers, Sanjeev V Thomas, Frank Vajda
Epilepsia | WILEY | Published : 2016
Awarded by Netherlands Epilepsy Foundation (NEF)
EURAP has received financial support from the following pharmaceutical companies: Bial, Eisai, GlaxoSmithKline, Janssen-Cilag, Novartis, Pfizer, Sanofi-Aventis, and UCB; from Netherlands Epilepsy Foundation (NEF) grant 03-18 (Lindhout); and from Stockholm County Council, ALF (Tomson). The sponsors had no influence on the conduct of the study, analysis, interpretation, or writing of the manuscript, or the decision to publish the results.